menu
    • menu

    Company profile for OMass Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    OMass is an Oxford University spin-out backed by Syncona Ltd and Oxford Sciences Innovation that is harnessing high-resolution native mass spectrometry and other biophysical technologies to drive drug discovery in high definition for immunology and genetic disease. OMass’ suite of proprietary technologies enables protein targets to be interrogated in a folded native-like state thereby preserving any associated non-covalent i...
    OMass is an Oxford University spin-out backed by Syncona Ltd and Oxford Sciences Innovation that is harnessing high-resolution native mass spectrometry and other biophysical technologies to drive drug discovery in high definition for immunology and genetic disease. OMass’ suite of proprietary technologies enables protein targets to be interrogated in a folded native-like state thereby preserving any associated non-covalent interactions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OMass Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    The Schrödinger Building, Heatley Road, The Oxford Science Park, Oxford
    Telephone
    Telephone
    01865 548350
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.omass.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/omass-therapeutics/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche Makes Preclinical IBD Play in $420M+ OMass Pact
    Roche Makes Preclinical IBD Play in $420M+ OMass Pact

    03 Sep 2025

    // BIOSPACE

    https://www.biospace.com/business/roche-makes-preclinical-ibd-play-in-420m-omass-pact

    BIOSPACE
    03 Sep 2025
    Share Share
    OMass Therapeutics names Carol A. Schafer Non-Executive Director
    OMass Therapeutics names Carol A. Schafer Non-Executive Director

    06 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/06/3128204/0/en/OMass-Therapeutics-Appoints-Carol-A-Schafer-as-Non-Executive-Director-and-Chair-of-the-Audit-Committee.html

    GLOBENEWSWIRE
    06 Aug 2025
    Share Share
    OMass Therapeutics Reveals Promising Data for MC2 Program
    OMass Therapeutics Reveals Promising Data for MC2 Program

    14 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/14/3114502/0/en/OMass-Therapeutics-Presents-Positive-Preclinical-Data-For-its-Best-in-class-MC2-Program-at-ENDO-2025.html

    GLOBENEWSWIRE
    14 Jul 2025
    Share Share
    OMass Therapeutics o Present Preclinical Data for MC2 Program
    OMass Therapeutics o Present Preclinical Data for MC2 Program

    07 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3110916/0/en/OMass-Therapeutics-to-Present-New-Preclinical-Data-For-its-Best-in-Class-MC2-Program-at-ENDO-2025.html

    GLOBENEWSWIRE
    07 Jul 2025
    Share Share
    OMass Therapeutics appoints Birgitte Volck as Director
    OMass Therapeutics appoints Birgitte Volck as Director

    26 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/26/3032608/0/en/OMass-Therapeutics-appoints-Birgitte-Volck-as-Non-Executive-Director.html

    GLOBENEWSWIRE
    26 Feb 2025
    Share Share
    OMass Therapeutics Expands Team With Key Appointments In US, UK
    OMass Therapeutics Expands Team With Key Appointments In US, UK

    01 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/10/01/2955794/0/en/OMass-Therapeutics-Expands-Development-Team-with-Key-Appointments-in-US-and-UK-and-Announces-the-Nomination-of-Clinical-Candidate-Against-MC2.html

    GLOBENEWSWIRE
    01 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search